Markets Today — Stock Prices, Movers and Analysis

SPCX rose 7.66% over the week, from $116.41 to $125.33, despite falling through July 31. The stock declined from $116.41 on July 28 to $108.37 on July 31, then reversed higher, gaining 5.68% on August 3 and 9.43% on August 4. The final two-session rebound more than offset the earlier losses, with August 4 volume reaching 144.1 million shares versus 70.5 million on August 3. The supplied evidence identifies no company-specific announcement, earnings release, contract, or guidance change explaining the move, and provides no broader market catalyst; the stock therefore appears to have moved on trading flows or sentiment not documented here.

Advanced Micro Devices, Inc.AMD · NASDAQ-GS

$486.796.13%

Prev close: $518.58
Volume: 35.53M
Market cap: 793.81B
P/E: —

AMD rose $63.96, or 14.07%, from $454.62 to $518.58 over the reported week. Trading was volatile: shares fell to $429.56 before rebounding to $485.39, then advanced again into the final session. The initial weakness reflected concern that the cost of scaling AMD’s data-center business outweighed its growth, despite data-center revenue doubling to $6.7 billion and quarterly revenue rising 50% to a record $11.5 billion. The subsequent recovery was driven by AMD’s second-quarter earnings and revenue beats, with reported surprises of 3.11% and 1.87%, respectively. Broader semiconductor strength, AI optimism, strong technology earnings and a wider market rally also supported the final move.

NVIDIA CorporationNVDA · NASDAQ-GS

$221.124.33%

Prev close: $211.94
Volume: 101.11M
Market cap: 5.35T
P/E: —

NVIDIA gained $14.93, or 7.58%, over the supplied period, rising from $197.01 on July 28 to $211.94 on August 4. The evidence does not identify a dated, company-specific catalyst for the move. Trading instead reflected continued enthusiasm around AI infrastructure demand, including discussion of NVIDIA’s robotics opportunity, data-center applications and strong spending by customers such as SpaceX, alongside broader semiconductor momentum. The stock fell 3.55% on July 29 to $190.01 before reversing higher, gaining on each subsequent session and recovering more than the initial decline. Articles also highlighted competitive and cyclical risks, including Alphabet’s custom Tensor Processing Units and concerns that heavy AI-infrastructure spending could pressure returns, but these did not prevent the weekly advance.

Eli Lilly and CompanyLLY · NYSE

$1,163.974.33%

Prev close: $1,115.68
Volume: 3.86M
Market cap: 1.10T
P/E: —

Eli Lilly fell 8.60%, from $1,220.66 to $1,115.68, declining in every reported session and reaching its lowest close on August 4 as volume rose to 4.10 million shares. The most identifiable company-specific development was the FDA’s Breakthrough Therapy designation for olomorasib in advanced pancreatic cancer, announced Monday, but it did not prevent a 2.4% decline that day. Investors were also positioning ahead of the August 5 earnings release, which was outside the reported trading window. Available evidence does not identify a negative company announcement during the week; the sustained retreat therefore appears driven mainly by pre-earnings positioning and broader reassessment of the stock’s valuation and growth expectations.